Are you attending the 2026 Life Sciences Future Southwest Annual Meeting? We’d love to see you there!

Event Details

• April 9, 2026
• Wyndham Grand Hotel, Pittsburgh, PA

Explore Our Services

Frontage Laboratories provides end-to-end analytical testing solutions for large molecule therapeutics, supporting projects from pre-IND to commercialization. Our expertise spans biologics, cell therapy, and gene therapy, delivering phase-appropriate methods for release and stability testing.

For small molecule programs, Frontage offers comprehensive CMC and analytical support across multiple dosage forms, including injectables, solid orals, capsules, semisolids, ophthalmics, and both sterile and non-sterile products. Our capabilities include pre-formulation, drug product development, analytical method development and validation, IVRT and IVPT (skin permeation), BABE studies, extractables and leachables testing, nitrosamine analysis, microbiological testing, ICH stability storage and testing, GLP batches, GMP clinical trial materials, scale-up, pilot and pivotal/registration batches, and commercial manufacturing.

Drug Modalities We Support

✔ Biologics – mAbs, ADCs, Therapeutic Proteins/Peptides, Vaccines
✔ Gene Therapy – Viral-based, Non-viral DNA/RNA
✔ Cell Therapy – CAR-T, TIL
✔ Plasmid QC

Key Services We Provide

• ​​​​​Molecular Assays
• Cell-Based Potency Assay
• Immunochemistry Assays (ELISAs, FACS, MSD, SPR)
• Advanced Biophysical Technologies (U/HPLC, CE/cIEF/CE-SDS, SEC-MS, DLS, AUC, LC/HRMS)
• Compendial Assays (Appearance, pH, Bioburden, Osmolality, Endotoxins, Sterility, Mycoplasma)
• Safety Assays (Adventitious Viruses, Replication-Competent Viruses)

John Stradling Director Business Development, CMC Services

Srikanth Manne Director Scientific Strategy & Business Development, CMC Services